News NICE okays neoadjuvant Opdivo in lung cancer BMS' checkpoint inhibitor is first to be given a green light for use before surgery in NSCLC.
News Regeneron is off to CHAPLE as FDA starts pozelimab review The C5 inhibitor is vying to become the first approved drug for the ultra-rare immune disorder.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
News CSL’s Hemgenix is first haemophilia B gene therapy in EU Firm will work with payers to try to secure access for as many patients across EU as possible.
News Travere undercuts key rival in rare kidney disease IgAN Filspari will launch for IgA Nepropathy at a discount to Calliditas' Tarpeyo, cleared in 2021.
News FDA undoes Astellas’ bid for fast review of menopause drug Pharma company had used a priority review voucher to speed up review of fezolinetant.
News FDA relents and will review Moderna's flu shot The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
